您的当前位置:首页 > 行业数据 > 65岁及以上人群两次接种mRNA-1273后各类不良反应发生概率
图片属性
图片格式:PNG 图片大小:137KB 图片尺寸:1948*690
同报告图片
 / 4
65岁及以上人群两次接种mRNA-1273后各类不良反应发生概率_第1页
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
65岁及以上人群两次接种mRNA-1273后各类不良反应发生概率_第2页
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
65岁及以上人群两次接种mRNA-1273后各类不良反应发生概率_第3页
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
65岁及以上人群两次接种mRNA-1273后各类不良反应发生概率_第4页
65岁及以上人群两次接种mRNA-1273后各类不良反应发生概率_第5页
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
所属报告: 医药生物行业2021年mRNA疫苗技术分析深度报告之一:mRNA疫苗开启疫苗行业新时代-210705(48页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠